Join
Live feed
·
INSIDERFilingvia Quantisnow
Cue Biopharma Inc. logo

Chief Executive Officer Lin Shao-Lee converted options into 109,179 shares and sold $1,606,562 worth of shares (58,258 units at $27.58), increasing direct ownership by 8% to 705,995 units (SEC Form 4) to cover withholding tax

ByQuantisnow·Wall Street's wire, on your screen.
CUE· Cue Biopharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CUE (Cue Biopharma Inc.) and more on Quantisnow.

Chief Executive Officer Lin Shao-Lee converted options into 109,179 shares and sold $1,606,562 worth of shares (58,258 units at $27.58), increasing direct ownership by 8% to 705,995 units (SEC Form 4) to cover withholding tax | Quantisnow